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Abstract
To understand the physiological function of glutaredoxin, a thiotransferase catalyzing the reduction of mixed disulfides of protein and glutathione,
we generated a line of knockout mice deficient in the cytosolic glutaredoxin 1 (Grx1). To our surprise, mice deficient in Grx1 were not more
susceptible to acute oxidative insults in models of heart and lung injury induced by ischemia/reperfusion and hyperoxia, respectively, suggesting that
either changes in S-glutathionylation status of cytosolic proteins are not the major cause of such tissue injury or developmental adaptation in the
Glrx1-knockout animals alters the response to oxidative insult. In contrast, mouse embryonic fibroblasts (MEFs) isolated from Grx1-deficient
mice displayed an increased vulnerability to diquat and paraquat, but they were not more susceptible to cell death induced by hydrogen peroxide
(H2O2) and diamide. A deficiency in Grx1 also sensitized MEFs to protein S-glutathionylation in response to H2O2 treatment and retarded
deglutathionylation of the S-glutathionylated proteins, especially for a single prominent protein band. Additional experiments showed that MEFs
lacking Grx1 were more tolerant to apoptosis induced by tumor necrosis factor αplus actinomycin D. These findings suggest that various oxidants
may damage the cells via distinct mechanisms in which the action of Grx1 may or may not be protective and Grx1 may exert its function on specific
target proteins.
© 2007 Elsevier Inc. All rights reserved.
Keywords: Reaction oxygen species; Protein glutathionylation; Thiol oxidation; Cell death; Gene targeting; Free radicals

Reactive oxygen species (ROS) have been shown to participate in the pathogenesis of many human diseases [1].
However, the biochemical mechanisms by which ROS cause
cell damage and ultimately organ dysfunction are not completely
understood. One of the major cellular targets of ROS is protein.
Abbreviations: ROS, reactive oxygen species; GSH, glutathione; protein–
SSG, protein–glutathione mixed disulfides; Grx1, glutaredoxin 1 protein;
Glrx1, glutaredoxin 1 gene; Trx, thioredoxin; PBS, phosphate-buffered saline;
MEFs, mouse embryonic fibroblasts; BAC, bacterial artificial chromosome;
TTC, triphenyltetrazolium chloride; D-PBS, Dulbecco's phosphate-buffered
saline; MTT, 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide;
diamide, azodicarboxylic acid bis (dimethylamide); diquat, 1,1′-ethylene-2,2′bipyridyldiylium dibromide; paraquat, 1,1′-dimethyl-4,4′-bipyridinium dichloride; TNFα, tumor necrosis factor α; AD, actinomycin D; LAD, left anterior
descending coronary artery.
⁎ Corresponding author. Fax: +1 313 577 0082.
E-mail address: yho@wayne.edu (Y.-S. Ho).
0891-5849/$ - see front matter © 2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.freeradbiomed.2007.07.025
This article is a U.S. government work, and is not subject to copyright in the United States.

ROS can oxidize both aliphatic and aromatic amino acid residues of proteins [2], leading to irreversible structural changes.
Additionally, the cysteine residues of proteins, particularly after
ionization to cysteine thiolate anions, are vulnerable to oxidation
to form sulfenic acids (–SOH). The cysteine sulfenic acids in
proteins are very unstable and can have several fates; they can
react readily with vicinal protein thiols or nonprotein thiols,
especially glutathione (GSH), to form intra- and interprotein
disulfides and mixed disulfides of proteins with GSH (protein–
SSG), respectively. Alternatively, in the absence of thiols in
close vicinity, they can be further oxidized to cysteine sulfinic
(RSO2H) and sulfonic (RSO3H) acids. The chemical changes
that result from thiol oxidation can affect the catalytic and/or
structural function of a protein.
Remarkably, cells are equipped with various enzyme systems
to specifically reduce most of these forms of oxidized thiols.
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Cysteine sulfinic acid is generally thought to represent an
irreversible oxidative product of protein thiols that can progress
to the sulfonic acid oxidation state. However, recent data have
documented an exception, showing that the sulfinic acid moiety
in 2-Cys peroxiredoxins in cells under oxidative stress can be
reduced by two ATP-dependent reductases, sulfiredoxin and
sestrin [3–6].
The other forms of oxidized protein thiols can be reduced by
two members of the thiol–disulfide oxidoreductase superfamily,
thioredoxin (Trx) and glutaredoxin (Grx), that contain conserved
Cys-X-X-Cys motifs and serve as hydrogen donors for
ribonucleotide reductase [7]. Although both Trx and Grx exhibit
activity in regeneration of oxidatively damaged proteins, further
studies have shown that they have different substrate preferences
[8,9]. Trx has been reported to preferentially reduce protein
sulfenic acids as well as intra- and interprotein disulfides. Two
isoforms of Trx have been found in mammals, Trx1 is located in
the cytosol and Trx2 in the mitochondria [10,11]; both function
in modulation of cellular redox signaling and in defense against
oxidant-mediated injury in vitro and in vivo [12].
Grx is believed to play a unique role in the repair of oxidized
protein thiols, specifically catalyzing the reduction of protein–
SSG [9,13]. Because GSH is the most abundant nonprotein thiol
in cells (at concentrations from 0.5 to 20 mM) [14], the majority
of protein mixed disulfides formed inside cells under oxidative
stress are protein–SSG and to a lesser extent intra- and
interprotein disulfides. For the latter two species of protein
disulfides, formation of intraprotein disulfides is believed to be
more favorable than that of interprotein disulfides in cells under
oxidative stress, because the chance of having two thiol groups
residing on two proteins in close vicinity is relatively low. The
protein–SSG mixed disulfides are reduced efficiently by Grx via
a monothiol mechanism involving a nucleophilic double
displacement reaction in which GSH serves to recycle the
enzyme [15]. Furthermore, previous tissue and cell culture
studies have indicated that glutathione-dependent catalysis by
Grx accounts for most of the deglutathionylation activity
[16,17]. Therefore, Grx is believed to play a pivotal role in
defense against oxidative stress and in redox regulation of
cellular function [13].
Two glutaredoxin (Glrx) genes have been characterized in
mammals. The Glrx1 gene encodes the cytosolic enzyme Grx1
[18]. The second Glrx (Glrx2) gene encodes two proteins as a
result of alteration of RNA splicing. One of the Grx2 isoforms is
expressed with an N-terminal leader sequence that directs it to
the mitochondria, and both have C-terminal sequences that
suggest nuclear localization [19,20]. As expected, cells overexpressing Grx1 are more resistant to doxorubicin-induced
toxicity compared to control cells [21]. In addition, treatment of
cultured cerebellar granule neurons with recombinant Grx
protein from Escherichia coli prevents cell death induced by
dopamine, and the protection seems to be mediated through
activation of the Ras/PI3K/Ref-1/Akt/NF-κB pathway [22,23].
This protective mechanism was further elaborated in another
study in which Grx1 overexpression was shown to protect H9c2
cells against toxicity of hydrogen peroxide (H2O2) [24].
Apparently, Grx1 maintains the level of phosphorylated Akt

(activated Akt), a general mediator of cellular survival signals,
by dissociating the interaction between Akt and protein
phosphatase 2A. Interestingly, Grx1 also affects other cellular
signaling pathways. Lee and colleagues showed that Grx1
protects cells against oxidant injury from glucose starvation,
probably through binding to the C-terminus of apoptosis signalregulating kinase 1 [25,26]. In addition, a number of studies with
a variety of cells in culture have documented a role for Grx1 in
regulation of redox signal transduction [13]. Despite these in
vitro studies, the function of Grx1 in vivo has not yet been
characterized. In this report, we describe the generation of a line
of knockout mice deficient in Grx1, along with tests of the
potential physiological consequences of the enzyme deficiency.
Materials and methods
Targeted disruption of the mouse Glrx1 gene
Custom polymerase chain reaction screening of a bacterial
artificial chromosome (BAC) library carrying strain 129SV
mouse genomic DNA was performed by Incyte Genomics
(St. Louis, MO, USA) using two pairs of primers derived from
the sequence of a mouse cDNA coding for Grx1 (NCBI
Accession No. AA239905). Three BAC clones (GS Control
Nos. 20424, 20428, and 20429) were identified from the
screening. Multiple DNA fragments from BAC clone 20424
were then subcloned into plasmid pKS (Stratagene, La Jolla,
CA, USA) and the DNA sequence was determined. The mouse
Glrx1 gene contains three exons and the protein coding sequence
is located in the first two exons (Fig. 1A). Exon 3 codes only for
the 3′ untranslated sequence of the mRNA. The structure of the
mouse Glrx1 gene is virtually identical to that of the human
gene, except intron 1 of the mouse gene is unusually long—
7.2 kb, compared to 1.0 kb in humans [27].
To construct the targeting vector, the 3.5-kb HindIII DNA
fragment containing the 5′ flanking sequence of the mouse
Glrx1 gene was first inserted into the HindIII site of plasmid pKS
with the direction of transcription of the mouse genomic DNA
fragment opposite to that of the ampicillin resistance gene
(coding for β-lactamase). The 3.5-kb HindIII DNA fragment
was subsequently released from the pKS vector by digestion
with enzymes KpnI and XbaI (which are located in the multiple
cloning sites of pKS vector) and cloned into the corresponding
sites in plasmid pPNT [28], resulting in plasmid pPNT-5′Glrx1.
The plasmid pPNT-5′Glrx1 was digested with KpnI and SalI,
blunt-ended by treatment with mung bean nuclease, and then
religated. These procedures removed the XhoI site, which was
derived from the multiple cloning sites of pKS, from plasmid
pPNT-5′Grx1 to generate plasmid pPNT-5′Glrx1(−X). To insert
the 3′ portion of the mouse Glrx1 gene into the targeting vector,
the 1.9-kb BamHI DNA fragment containing exon 3 of the
mouse Glrx1 gene was initially inserted into the BamHI site of
plasmid pKS with transcription direction opposite to that of the
ampicillin resistance gene. This BamHI DNA fragment was then
removed from the pKS plasmid by digestion with enzymes XhoI
and NotI (which sites are located in the multiple cloning sites of
pKS vector) and cloned into the corresponding sites in plasmid
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Fig. 1. Targeted disruption of the mouse Glrx1 gene. (A) Genomic structure and partial restriction maps of the mouse Glrx1 locus (top), the targeting vector (middle),
and the targeted locus (bottom) are shown. The open and black boxes represent the protein coding regions and noncoding regions in the exons. The number of the exon
is indicated under each exon. The shaded box on top of the restriction map of the Glrx1 locus represents the 3′ external sequence used for probing the DNA blot filters.
B, BamHI; E, EcoRI; H, HindIII; N, NotI; P, PstI; neo, neomycin resistance cassette; TK, herpes thymidine kinase gene under the control of the mouse promoter for the
phosphoglycerate kinase-1 gene [33]. Arrows show the directions of transcription of the neo and TK genes. The sizes of the PstI restriction fragments from the wildtype and targeted loci hybridized with the probe are shown on the top and bottom, respectively. (B) DNA blot analysis of wild-type, heterozygous Glrx1 knockout, and
homozygous Glrx1 knockout mice. DNA isolated from mouse tails was digested with PstI and probed with the 3′ external probe shown in (A). +/+, +/−, and −/−
represent wild-type, heterozygous Glrx1 knockout, and homozygous Glrx1 knockout mice, respectively. The 4.3 kb hybridization band is derived from the wild-type
allele, and the 2.9 kb hybridization band from the mutated allele.

pPNT-5′Glrx1(−X). The resulting targeting vector, in which
exons 1 and 2 were replaced by a neomycin resistance cassette,
was linearized with NotI digestion and then transfected into R1
embryonic stem (ES) cells [29]. Fourteen clones (2.8%) were
identified from a total of 503 clones screened to contain the
targeted Grx1 allele. Chimeric mice were then generated by
microinjecting clones 118 and 256 into blastocysts isolated from
strain C57BL/6 mice [30]. All chimeric mice transmitted the
targeted Glrx1 allele into offspring. Heterozygous knockout
mice were interbred to generate homozygous knockout mice.
Preparation of tissue samples for gene expression studies
Tissues from wild-type (Glrx1+/+ ), heterozygous Glrx1
knockout (Glrx1 +/− ), and homozygous Glrx1 knockout
(Glrx1−/− ) mice were homogenized in guanidinium isothiocyanate solution, and total RNA was isolated according to the
method described Chirgwin et al. [31]. Thirty micrograms of
total RNA was denatured with glyoxyal and subjected to blot
analysis according to the procedures described by Thomas [32].
For protein analysis, the tissues were homogenized in 1.5 to 2 ml
of lysis buffer (50 mM potassium phosphate buffer, pH 7.8,
0.5% Triton X-100, and 3% glycerol) containing protease
inhibitor cocktail (P-8340; Sigma, St. Louis, MO, USA) and

1 mM phenylmethylsulfonyl fluoride with a Polytron homogenizer, followed by sonication. The homogenates were clarified
by centrifugation at 20,000 g for 15 min and stored at − 70°C.
Protein concentrations of tissue homogenates were determined
by the use of a bicinchoninic acid (BCA) protein assay kit
(Pierce, Rockford, IL, USA). Thirty micrograms of tissue
protein were separated on a SDS–polyacrylamide gel for protein
blot analysis. The protein blot membrane was reacted with
polyclonal antibodies against the human Grx1 protein generated
in rabbits (kindly provided by Dr. Marjorie Lou of the University
of Nebraska at Lincoln, Lincoln, NE, USA) and then with
polyclonal antibodies against copper–zinc superoxide dismutase (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
To understand the effect of Grx1 deficiency on expression of
different antioxidant enzymes, heart and lung homogenates
prepared from six Glrx1+/+ mice and six Glrx1−/− mice were
subjected to protein blot analysis using antibodies against
copper–zinc and manganese superoxide dismutases (Santa Cruz
Biotechnology). In addition, the activity of catalase was measured by monitoring the decrease in absorbance of hydrogen
peroxide at 240 nm [33]. Hydrogen peroxide was also used as a
substrate for determining the activity of glutathione peroxidase
in a reaction coupled to NADPH oxidation in the presence of
sodium azide, which inhibits the activity of catalase [34].
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Preparation of tissue samples and assay for activity of Grx
Frozen tissue samples were thawed on ice and 100 mg of each
was weighed and transferred to individual 15-ml conical tubes
prechilled on ice. Then 1.5 ml of complete homogenization
buffer [0.1 M K-monobasic/Na-dibasic, pH 7.5, supplemented
with protease inhibitors aprotinin and leupeptin (20 ng/ml)] was
added to each tube and homogenized twice for 30 s on ice using a
Polytron homogenizer. The homogenates obtained were transferred to 2-ml centrifuge tubes and centrifuged at 100 g for
10 min at 4°C (to remove the cell debris). The supernatant (free
of cell debris) was transferred into fresh 1.5-ml tubes and
centrifuged at 10,000 g for 30 min at 4°C. The resulting
supernatant was used for assays of protein content and Grx
activity.
Bovine serum albumin–[35S]SSG mixed disulfide ([35S]
BSA–SSG) was used as substrate in a radiolabel assay for
determining glutaredoxin activity. [35S]BSA–SSG was prepared
as described previously with the following modifications [35].
S-carboxymethyl BSA was initially reacted with N-succinimidylpyridyl bis (3,3′-dithiopropionate) and the reaction was then
quenched with glycine. The modified BSA was subsequently
separated from small molecules by dialysis against 100 mM
sodium phosphate, pH 7.0, overnight with two changes of buffer,
followed by reaction with 4 mM [35S]GSH for 1 h at room
temperature. The resulting [35S]BSA–SSG product was separated from [35S]GSH by G-25 chromatography, and it typically
had ≥ 0.9 GS eq/mol of BSA.
The activity of Grx's in mouse tissues was measured by
monitoring the time-dependent release of radioactivity from
[35S]BSA–SSG. This assay of GSH-dependent deglutathionylation of protein–SSG is highly selective for Grx [17]. Also, the
radiolabel assay avoids the multiple flaws associated with the
GSSG reductase-coupled spectrophotometric analysis of tissue
homogenates, including interference by light scattering and
nonspecific NADPH oxidase activity. Aliquots of homogenates
and assay buffer (0.1 M Na/K phosphate buffer, pH 7.4,
containing 0.5 mM GSH and 0.2 mM NADPH) were prewarmed
to 30°C and mixed, and then an aliquot of [35S]BSA–SSG (final
concentration of 0.1 mM) was added to initiate the reaction (total
volume 0.5 ml). Aliquots of the reaction mixtures were
precipitated with ice-cold trichloroacetic acid (final concentration of 10%) at 12 s and 1, 2, and 3 min of incubation. After
centrifugation, the supernatants were analyzed for 35S by
scintillation counting with ≥ 97% efficiency (cpm). The total
rates of deglutathionylation (slopes of [35S]GSH eq released
versus time) were corrected for nonenzymatic deglutathionylation by subtracting the rate of [35S]GSH eq released by GSH in
the absence of tissue homogenates. Enzymatic rates are
expressed as nmol of product/min/mg of protein.
Mouse model of regional ischemia/reperfusion-induced heart
injury
Five Glrx1+/+ and six Glrx1−/− mice at 10 to 12 weeks of age
were anesthetized with tribromoethanol (275 mg/kg, ip). An
endotracheal tube (PE 90) was inserted into the trachea

approximately 5 to 8 mm past the larynx, and the mice were
ventilated with room air (a tidal volume of 0.5 ml) using a rodent
respirator (Columbus Instruments International, Columbus, OH,
USA) set at a respiratory rate of 110–120 breaths/min. The heart
was exposed through a left thoracotomy incision and the left
anterior descending coronary artery (LAD) was ligated as described previously [36]. The chest was then closed after LAD
ligation. After 60 mn of LAD ligation, the ligature was released
to allow reperfusion for 4 h. The mouse was again anesthetized
with tribromoethanol. At the dose of tribromoethanol used, there
was no loss of animals due to repeated anesthesia. The heart was
then perfused as a Langendorff preparation for 5 min. The left
coronary artery was reoccluded, and 1% Evans blue was infused
into the aorta and coronary arteries to determine the area at risk.
The heart was then cut transversely into five sections, with one
section made at the site of the ligature, and stained with
triphenyltetrazolium chloride (TTC) for measurement of the
infarct size as described previously [36]. The area at risk (unstained by Evans blue) was expressed as a percentage of the left
ventricle (LV). The infarct size (area unstained by TTC) was
expressed both as a percentage of the area at risk and as a
percentage of LV [39]. The animal protocol was approved by the
Animal Care Committee of East Tennessee State University.
Assessment of hyperoxia-induced lung injury in mice
The Glrx1+/+ and Glrx1−/− mice at 10 weeks of age were
used in exposure to N 99% oxygen in polystyrene chambers.
The CO2 concentration was maintained at less than 5% by
providing approximately 12 complete gas exchanges per hour.
During the exposure, food and water ad libitum were provided,
and the mice were kept under a 12 h on, 12 h off light cycle at
all times. The mice were sacrificed at 72 h of exposure by
overdose of pentobarbital and the lungs isolated. The left lobe
was gently blotted dry with a piece of paper towel and the total
weight (wet weight) measured. The lungs were then dried at
80°C under vacuum overnight and weigh again to measure the
dry weight.
The extent of lung injury was also assessed by measuring the
increases in protein content and number of neutrophils in
bronchoalveolar lavage fluid (BALF). To do so, a second group
of Glrx1+/+ and Glrx1−/− mice was exposed to air or N 99%
oxygen for 72 h. Mice were then anesthetized with pentobarbital
and the trachea was exposed. A Microfil needle (World Precision
Instrument, Sarasota, FL, USA) was then inserted into the
trachea through a small incision and fastened with a silk ligature
around the trachea. Bronchoalveolar lavage was performed with
1 ml phosphate-buffered saline (PBS) containing 3 mM EDTA
using a 1-ml syringe and repeated five times. The collected
bronchoalveolar lavage fluid (BALF) (a total of 5 ml) was
centrifuged at 1800 g to pellet the cells. The protein content in
the supernatant was determined using a BCA assay kit. The
pelleted cells were washed once and resuspended in 0.3 ml of
PBS containing EDTA, followed by dilution of 100 μl of the cell
suspension to 10-fold with the same buffer. Two hundred
microliters of the diluted cell suspension was cytocentrifuged
and stained with the Hema 3 System (Fisher Scientific,
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Pittsburgh, PA, USA). The total number of neutrophils in a total
of 200 white blood cells was counted. To determine the total
numbers of cells in BALF samples, 10 μl of the cell suspension
was added to 10 ml of Isoton diluent, followed by addition of 2
drops of Zap-O-Globin II lytic reagent to lyse red blood cells.
The remaining intact cells (mainly white blood cells) were then
counted with the Z1 Coulter Counter (Beckman Coulter, Inc.,
Fullerton, CA, USA). This allowed the estimation of the absolute number of neutrophils in BALF.
Preparation of mouse embryonic fibroblasts (MEFs)
The homozygous Glrx1 knockout mice in a 129SV and
C57BL/6 hybrid background and genetically matched wild-type
mice were used for preparation of MEFs. Briefly, mouse
embryos were dissected out from the pregnant dams 12.5 to 14.5
days postcoitus and internal organs removed. The embryos were
then chopped into small pieces and stirred in 50 ml of Hanks'
balanced salt solution (without calcium and magnesium)
containing 0.05% trypsin and 0.53 mM EDTA (25300-054;
Invitrogen, Carlsbad, CA, USA) in an Erlenmeyer flask at 37°C
for 1 h. Ten illigrams of DNase was added at the end of the
incubation to decrease the viscosity of the cell suspension due to
lysis of cells. The cell suspension was then passed through two
layers of cheese cloth to remove the undigested and large chunks
of tissues. The cells were then collected by centrifugation and
cultured in Dulbecco's modified Eagle medium (Cat. No.
11995-065; Invitrogen) containing 10% fetal bovine serum,
penicillin, and streptomycin. MEFs from passages 2 to 4 were
used for the study.
Determination of cytotoxicity in MEFs by
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide
(MTT) reduction and trypan blue assay
Twenty-four-well culture plates, each well seeded with
2 × 105 MEFs prepared from either Glrx1+/+ or Glrx1−/− mice,
were used for cytotoxicity studies. For studying H2O2-induced
cell death, the overnight cultures of MEFs were washed once
with Dulbecco's phosphate-buffered saline (D-PBS; Base Cat.
No. 14040; Invitrogen) supplemented with glucose (1 g/liter)
and then treated with the same solution containing various
concentrations of H2O2 (1 ml/well) at 37°C with 5% CO2 for 1 h.
The D-PBS was removed at the end of treatment and cells were
further incubated in 1 ml of culture medium containing 0.5 mg
MTT for 3 h. The MTT medium was subsequently removed and
replaced with 0.5 ml of isopropyl alcohol containing 0.01 N HCl
to dissolve the formazan crystals that were formed from
reduction of MTT in the cells [37]. Then 0.2 ml of the dissolved
formazan was transferred into a 96-well plate and the absorbance
at 570 nm measured using the SPECTRAmax Microplate
Spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).
The net absorbance from the wells of MEFs treated with D-PBS
without H2O2 was taken as 100% of MTT reduction. Cell
viability was calculated by dividing the absorbance of H2O2treated MEFs by that of the same MEFs treated with D-PBS
without H2O2.
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The same procedures were also used for quantifying cell
viability after treatment with diamide [azodicarboxylic acid bis
(dimethylamide)], diquat (1,1′-ethylene-2,2′-bipyridyldiylium
dibromide), paraquat (1,1′-dimethyl-4,4′-bipyridinium dichloride), and tumor necrosis factor α(TNFα) plus actinomycin
D, except the cells were treated in culture medium instead of
D-PBS, and the treatment lasted 24 h.
The extent of cell death was also assessed by a trypan blue
exclusion assay. Briefly, MEFs were washed with D-PBS and
trypsinized at the end of treatment. Fetal bovine serum was then
added to the cell suspension to a final concentration of 10% to
stop the trypsinization, followed by staining with 0.2% trypan
blue for 5 min. The numbers of dead, dark-blue-stained cells and
live, unstained cells were counted using a hemocytometer.
Detection of protein S-glutathionylation in MEFs by protein
blot analysis
For determining the effect of Grx1 deficiency on protein
S-glutathionylation, 35-mm culture dishes, each seeded with
5 × 105 Glrx1+/+ or Glrx1−/− MEFs, were treated with 2.5 ml of
D-PBS containing glucose (1 g/liter) and various concentrations
of H2O2 for 1 h as described above. At the end of treatment, the
attached cells were scraped into the D-PBS in which they were
treated (including the floating cells as a result of detachment of
cell monolayers due to treatment) and then precipitated by
centrifugation. The cell pellet was resuspended in 0.3 ml of lysis
buffer (50 mM potassium phosphate buffer, pH 7.8, containing
0.5% Triton X-100, 3% glycerol) containing protease inhibitor
cocktail (P-8340; Sigma), 1 mM phenylmethylsulfonyl fluoride,
and 28.5 mM N-ethylmaleimide to prevent S-glutathionylation
of proteins during sample manipulation. The cells were then lysed
by freezing and thawing once, followed by sonication. The cell
lysate was clarified by centrifugation and protein concentration
determined by the use of a BCA protein assay kit (Pierce). Total
cellular proteins were then separated on a nonreducing SDS–
polyacrylamide gel and transferred to a piece of nitrocellulose
membrane. The protein blot membrane was reacted with a
monoclonal antibody against GSH (ViroGen, Watertown, MA,
USA), followed by the standard procedures of chemiluminescence to visualize the antibody-interactive proteins.
Statistical analysis
The data were first analyzed by one-way analysis of variance
followed by Newman–Keuls multiple comparison. For myocardial ischemia/reperfusion study, the difference between two
groups was established by Student's t test. Differences with a p
value b 0.05 were considered statistically significant.
Results
Generation and characterization of knockout mice deficient in
Grx1
We have previously generated a line of Glrx1 knockout mice
in which exon 2 and parts of introns 1 and 2 of the mouse Glrx1
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gene were replaced by a neomycin resistance cassette. Unexpectedly, a species of Glrx1 mRNA smaller than the wildtype Glrx1 mRNA, presumably resulting from a fusion of exons
1 and 3 of the gene, is expressed in all tissues of homozygous
knockout mice examined (Ho et al., unpublished data). We
therefore repeated gene targeting of ES cells using a new
construct in which both exons 1 and 2 of the mouse Glrx1 gene
were deleted (Fig. 1A). Chimeric mice generated from the
targeted ES cells successfully transmitted the mutated Glrx1
allele to their offspring and homozygous knockout mice were
generated by interbreeding two heterozygous knockout mice
(Fig. 1B).
An expression study was then performed to demonstrate that
deletion of exons 1 and 2 inactivates the mouse Glrx1 gene. As
shown in Fig. 2A, an approximately 50% decrease in Glrx1
mRNA was found in tissues of Glrx1+/− mice in comparison to
Glrx1+/+ mice, and no Glrx1 mRNA could be detected in tissues
of Glrx1−/− mice. To determine whether expression of the Glrx2
gene is altered in tissues of Glrx1 knockout mice, the same RNA
blot membrane was rehybridized with a mouse cDNA coding for
Grx2. When standardized against the mRNA level of glyceraldehyde-3-phosphate dehydrogenase (Gapd), the levels of
Glrx2 mRNA in brain, kidney, liver, and lungs of mice with
three different Glrx1 genotypes were equivalent (Fig. 2A). (Note
that less RNA from brain and kidney of a Glrx1−/− mouse was
loaded on the gel compared to that from the corresponding

tissues of Glrx1+/+ and Glrx1+/− mice, as revealed by the levels
of Gapd mRNA.) However, the level of Glrx2 mRNA in the
heart of a Glrx1−/− mouse is slightly decreased relative to those
of Glrx1+/+ and Glrx1+/− mice.
Abolishment of Grx1 expression in tissues of Glrx1−/−
mice was also confirmed by protein blot analysis (Fig. 2B),
in which cytosolic copper–zinc superoxide dismutase
(CuZnSOD) was used as the loading control because its
specific content was unchanged in tissues of the knockout
mice (see below). In addition, the specific Grx activity in
tissue homogenates of Glrx1−/− mice was also determined. In
all cases there was a lack of detectable deglutathionylase
activity in homogenates of the five tissues from the homozygous knockout mice. These data also indicate that the
contribution of mitochondrial and nuclear Grx2 to total Grx
activity in these mouse tissues is negligible and that no compensatory deglutathionylase activity is developed in the knockout mice.
To determine whether a deficiency in Grx1 affects expression of other antioxidant enzymes in heart and lungs, the
activities of catalase and glutathione peroxidase were determined by activity assays and the levels of copper–zinc and
manganese superoxide dismutases measured by protein blot
studies. No changes in the activities and protein levels of these
enzymes could be found in these two organs of Grx1-deficient
mice compared to those of wild-type mice (data not shown).

Fig. 2. Expression analysis of Glrx1 knockout mice. (A) RNA blot analysis of Glrx1 mRNA expression in tissues of wild-type and Glrx1 knockout mice. The RNA
blot membrane was first hybridized with a mouse Glrx1 cDNA and then rehybridized with a mouse cDNA for glutaredoxin 2 (Glrx2) (kindly provided by Dr. V. N.
Gladyshev of the University of Nebraska at Lincoln) and then a rat cDNA for glyceraldehyde-3-phosphate dehydrogenase (Gapd). (B) Protein blot analysis of Glrx1 in
tissues of wild-type and Glrx1 knockout mice. The protein blot membrane was initially reacted with rabbit anti-human Grx1 antibodies and then re-reacted with rabbit
anti-human copper–zinc superoxide dismutase (CuZnSOD) antibodies. In (A) and (B), +/+, +/−, and −/− represent wild-type, heterozygous Glrx1 knockout, and
homozygous Glrx1 knockout mice, respectively.
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expression of manganese superoxide dismutase, extracellular
superoxide dismutase (ECSOD), or 1-Cys peroxiredoxin
(Prdx6) in the lungs of transgenic mice greatly attenuates lung
damage resulting from exposure to hyperoxia [44–46]. Conversely, knockout mice deficient in ECSOD or Prdx6 are
particularly vulnerable to the same model of lung injury [47,48].

Fig. 3. Lack of effect of Grx1 deficiency on myocardial infarction in mice.
Animals were subjected to 60 min of LAD coronary artery ligation followed by
4 h of reperfusion. The infarct size was standardized against LV and area at risk
(AR). Each bar represents the mean ± SD.

The deficiency in Grx1 seems to have very limited effect on
mouse development and physiology in general, because the
homozygous knockout mice are healthy and fertile upon observation until 1 year of age.
Mice deficient in Grx1 do not display greater myocardial injury
after an ischemia/reperfusion insult
ROS have been postulated to participate in the pathogenesis
of ischemia/reperfusion (I/R)-induced heart injury [1]. This
hypothesis is supported by the findings that knockout mice
deficient in CuZnSOD or cellular glutathione peroxidase are
more sensitive to cardiac I/R injury, and transgenic mice
overexpressing either of these enzymes exhibit a resistant
phenotype [38–42]. Analogously, overexpression of Grx1 in
H9c2 cardiomyocyte cells in vitro protects them from H2O2induced apoptosis [24]; however, an in vivo effect of genetic
manipulation of Grx1 has not been reported. The newly
generated Glrx1 knockout mice allowed us to investigate
whether a deficiency in Grx1 renders mice more susceptible to
regional I/R injury in vivo. Toward this end, Glrx1+/+ and
Glrx1−/− mice were subjected to 60 min of LAD ligation,
followed by 4 h of reperfusion. As shown in Fig. 3, the areas at
risk, expressed as the percentage of the LV, in hearts of Glrx1+/+
and Glrx1−/− mice were comparable (46 ± 6% vs. 43 ± 5%,
respectively). The infarct sizes of hearts of Glrx1+/+ and
Glrx1−/− mice, standardized against either LV or area at risk,
were equivalent (p N 0.05). These results indicate that a
deficiency in Grx1 does not affect the infarct size in mouse
hearts in an in vivo I/R model.
Deficiency in Grx1 does not increase hyperoxia-induced lung
injury in mice
Exposure of animals to hyperoxia is known to cause an
increased production of ROS in the lungs, leading to destruction
of alveolar epithelium, inflammation, edema, and eventually
death of animals [43]. Previous studies have shown that over-

Fig. 4. Lung injury in Glrx1+/+ and Glrx1−/− mice after exposure to N99%
oxygen for 72 h. (A) The extents of lung edema (wet/dry ratio) are equivalent in
both types of mice after exposure to hyperoxia. ∗p b 0.05 vs. Glrx1+/+ mice
exposed to air. ∗∗p b 0.01 vs. Glrx1−/− mice exposed to air. In (B) and (C),
hyperoxic exposure drastically increases the protein content and neutrophil
count in BALF of both types of mice compared to those of the corresponding
mice exposed to air. However, the extent of injury determined by these two
parameters is not affected by the different Glrx1 genotypes in the mice. #p b
0.001 vs. mice with the same genotype exposed to air. In (C), the total numbers
of neutrophils in the BALF of Glrx1+/+ and Glrx1−/− mice exposed to air were
less than 103 per mouse. In (A), (B), and (C), N ≥ 4 for each group of mice and
each bar represents the mean ± SD.
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These data have demonstrated the role of oxidative stress in
hyperoxia-induced lung damage as well as the protective
function of various antioxidant enzymes. However, the molecular and cellular mechanisms by which ROS cause lung
injury are not understood. The available Glrx1 knockout
allowed us to investigate whether a decreased capacity in
Grx1-mediated deglutathionylation of proteins would sensitize
mice to hyperoxia-induced lung injury. As shown in Fig. 4A,
exposure to N 99% oxygen caused lung edema in both
Glrx1+/+ and Glrx1−/− mice as evident by the increased lung
wet-to-dry ratios. Although the wet-to-dry ratio of Grx1deficient lungs (7.2 ± 1.1) is higher than that of wild-type
lungs (6.2 ± 1.1), the difference is not statistically significant.
The extent of lung injury was also assessed by measuring the
changes in protein content and neutrophil count in BALF. As
shown in Figs. 4B and 4C, exposure to hyperoxia drastically
increases the protein content and neutrophil count in BALF of
both types of mice compared to the corresponding mice
exposed to air (Figs. 4B and 4C). However, these two
parameters are not significantly different in lungs of Glrx1+/+
and Glrx1−/− mice after exposure to hyperoxia. These data
further support the conclusion derived from studies using lung

wet-to-dry ratio that Grx1 plays a very limited role in preventing
hyperoxia-induced lung injury.
Grx1-deficient MEFs are more susceptible to cell damage
induced by diquat and paraquat than by H2O2 and diamide
The function of Grx1 in cell defense against oxidative stress
was also studied in fibroblasts prepared from embryos of
Glrx1+/+ and Glrx1−/− mice. Fig. 5 shows the dose-dependent
decrease in viability of MEFs as determined by the decline in the
capability of the cells to reduce MTT after treatment with various
oxidants. The time points of treatment were determined in
separate experiments (data not shown) and were 1 h for treatment
with H2O2 and 24 h for diamide, diquat, and paraquat. As shown
in Fig. 5A, a deficiency in Grx1 does not render MEFs more
susceptible to loss of cell viability due to toxicity of H2O2.
Likewise, treatment of MEFs with diamide, a thiol-oxidizing
agent, is not more potent in decreasing viability of Grx1deficient MEFs compared to its effect on wild-type MEFs (Fig.
5B). On the other hand, MEFs lacking Grx1 are more vulnerable
to cell damage induced by either diquat or paraquat, two
chemicals that generate superoxide anion radical through the

Fig. 5. The susceptibility of MEFs to oxidant-induced cell damage. MEFs isolated from Glrx1+/+ and Glrx1−/− mice were treated (A) with various concentrations of
H2O2 in D-PBS for 1 h or with various concentrations of (B) diamide, (C) diquat, or (D) paraquat in culture medium for 24 h. Cell viability was determined by the MTT
assay. Results are shown as the percentage absorbance of oxidant-treated MEFs compared to that of the same MEFs cultured in D-PBS or medium without oxidants.
The data from Glrx1+/+ and Glrx1−/− MEFs with the same treatment were compared. Data are representative of at least three independent experiments. Each bar
represents the mean ± SD, n = 4 measurements. ∗p b 0.001, Glrx1+/+ MEFs vs. Glrx1−/− MEFs with the same treatment.
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Fig. 6. Morphology of MEFs treated with diquat and paraquat. Glrx1+/+ and Glrx1−/− MEFs were cultured in medium in the absence (as control) or presence of
0.05 mM diquat or 0.4 mM paraquat at 37°C for 24 h. The genotypes of the MEFs and the treatments are shown on the top and the left, respectively. A more extensive
detachment of cell monolayer and more cell death (shown as rounded cells) were seen in Glrx1−/− MEFs treated with diquat or paraquat compared to Glrx1+/+ MEFs.

redox cycling mechanism (Figs. 5C and 5D). The increased
susceptibility of Grx1-deficient MEFs to diquat and paraquat
can also be concluded from the severity of morphological
changes of the cells after treatment (Fig. 6).
The extent of cell death was also determined by a trypan blue
exclusion assay in which trypan blue penetrates and stains only
dead cells with permeable cell membranes. The results agree
with those obtained from MTT studies as shown in Fig. 5 (data
not shown).
Grx1-deficient MEFs are more resistant to apoptosis induced
by tumor necrosis factor α plus actinomycin D
The involvement of ROS in cell apoptosis has been
implicated in numerous studies [49]. We therefore determined
whether a deficiency in Grx1 affects the execution of the cell
apoptotic pathway. As shown in Fig. 7, apoptosis induced with
tumor necrosis factor α plus actinomycin D causes a 36%
decrease in viability of wild-type MEFs compared to controls,
and the extent of cell death is attenuated in MEFs deficient in
Grx1, suggesting a proapoptotic rather than an antiapoptotic role

Fig. 7. Grx1-deficient MEFs are more tolerant to apoptosis induced by TNFα
plus actinomycin D. Glrx1+/+ and Glrx1−/− MEFs were cultured in medium in
the absence (as control) or presence of 10 ng/ml TNFα plus 50 ng/ml
actinomycin D (AD) at 37°C for 24 h. Cell viability was determined by the MTT
assay as described for Fig. 5. Data are representative of two independent
experiments. Each bar represents the mean ± SD, n = 4 measurements. ∗p b
0.001, Glrx1+/+ MEFs vs. Glrx1−/− MEFs.

1308

Y.-S. Ho et al. / Free Radical Biology & Medicine 43 (2007) 1299–1312

for Grx1 in this context. This result is analogous to findings
reported recently in a study of hypoxia-induced apoptosis in
pancreatic carcinoma cells [50].
Grx1 deficiency affects formation and reduction of
protein–SSG mixed disulfides in MEFs in response to oxidative
stress
Because Grx1 catalyzes deglutathionylation of protein–SSG
mixed disulfides, we sought to investigate whether a deficiency
in Grx1 affects the extent of S-glutathionylated proteins in MEFs
in response to treatment with H2O2. As shown in Fig. 8A, two
proteins that comigrate with the reduced proteins of 44 and
34 kDa on the gel become more prominently S-glutathionylated
in Grx1-deficient MEFs compared to wild-type MEFs after
treatment with H2O2 at concentrations of 0.5, 1, and 2 mM. The
levels of S-glutathionylation of other higher molecular weight
proteins were markedly increased in both Glrx1+/+ and Glrx1−/−
MEFs after being treated with 5 mM H2O2 for 1 h, but the
protein–SSG levels in the Glrx1−/− cells were clearly higher
than those in the Glrx1+/+ cells. These observations indicate that

cells deficient in Grx1 are more susceptible to H2O2-induced
accumulation of S-glutathionylated proteins. We then examined
the time course of deglutathionylation of the protein–SSG
mixed disulfides that are formed due to H2O2 treatment. In this
experiment, MEFs were treated with 5 mM H2O2 for 1 h and then
cultured in regular medium in the absence of H2O2 for various
periods of time before harvest for measurement of S-glutathionylated proteins. As shown in Fig. 8B, the glutathionyl moiety of
most of the S-glutathionylated proteins, with the exception of a
few high-molecular-weight proteins, is removed in wild-type
MEFs within 1 h after termination of H2O2 treatment, consistent
with rapid Grx1-catalyzed deglutathionylation, which occurs
within minutes for most cellular proteins [22]. For Grx1deficient MEFs also, the majority of protein–SSG mixed
disulfides were deglutathionylated at 1 h, consistent with a
typical nonenzymatic time course. There was a notable
exception; namely deglutathionylation of an unidentified protein
which comigrated with a reduced standard protein of 44 kDa on
the gel was particularly decreased in the absence of Grx1 so that
it remained extensively S-glutathionylated in Glrx1−/− cells
even at 3 h after removal of H2O2.

Fig. 8. Formation and decay of protein–SSG mixed disulfides in Glrx1+/+ and Glrx1−/− MEFs treated with 5 mM H2O2. (A) S-glutathionylation of proteins in Glrx1+/+
and Glrx1−/− MEFs in response to various concentrations of H2O2. The cells were treated with H2O2 in D-PBS for 1 h and total proteins were separated on a 12% SDS
gel without the use of reducing agent (β-mercaptoethanol) for blot analysis using an anti-GSH antibody. The two S-glutathionylated proteins that comigrate with
reduced protein standards of 44 and 34 kDa are indicated by arrows on the right. (B) Reversal of protein S-glutathionylation in Glrx1+/+ and Glrx1−/− MEFs. The cells
were treated with 5 mM H2O2 in D-PBS for 1 h and then cultured in regular medium for various periods of time before being harvested for blot analysis as described for
(A). The proteins were separated on a 10% nonreducing SDS gel to allow better separation of the high-molecular-weight proteins. The S-glutathionylated protein
comigrating with a reduced protein of 44 kDa is indicated by an arrow on the right.
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Discussion
In eukaryotes, a precise control of oxidation/reduction of
protein thiols is essential for normal cell physiology. For
example, formation of intra- and interprotein disulfides is
required for maturation, secretion, and function of a large
number of secretory proteins and is also critical for the function
of some of the intracellular proteins. Oxidative protein folding in
the endoplasmic reticulum (ER) of cells can be catalyzed by
protein disulfide isomerase, which is maintained in its oxidized
state by Ero1 (ER oxidoreductin 1), as well as by members
belonging to the family of quiescin-sulfhydryl oxidase (QSOX)
[51,52]. In addition, Erv1p, a member of the QSOX family that is
located in the mitochondrial intermembrane space, is involved in
mitochondrial biogenesis and assembly of cytosolic iron–sulfur
cluster-containing proteins [53,54], suggesting the role of
disulfide bond formation in these critical cellular processes.
These observations illustrate the importance of thiol oxidation in
normal protein function and cell physiology. On the other hand,
the cytosolic compartment of cells is highly reduced and
therefore most of the cysteine residues of intracellular proteins
are in the reduced state. For these proteins, thiol oxidation as a
result of oxidative stress may represent an undesirable event.
Fortunately, certain forms of oxidized protein thiols can be
reduced by members of the thioredoxin fold family, Trx and Grx.
This study set out to further our understanding of the in vivo
functions of Grx1 using a line of knockout mice deficient in this
enzyme. In contrast to mice deficient in Trx1 or Trx2, which die
in utero [55,56], mice lacking Grx1 develop normally and are
healthy upon observation to 1 year of age, indicating the distinct
functions of Trx's and Grx1 in mouse development.
Due to the high intracellular concentration of GSH, Sglutathionylation of proteins occurs in cells under normal
culturing conditions and is further enhanced in cells under
oxidative stress (Fig. 7A). S-glutathionylation can inactivate the
catalytic function of many proteins such as transcription factors
NF-κB and NF-1 [50,57,58], protein tyrosine phosphatase 1B
(PTP-1B) [59,60], and protein kinase C-α[61]. However, the
activities of a number of other proteins, such as HIV-1 protease,
glutathione S-transferase, and Ras, are enhanced by Sglutathionylation [62–64]. In certain cases, the altered protein
function due to S-glutathionylation has been shown to play a role
in the regulation of cell physiology. For example, S-glutathionylation-mediated inactivation of PTP-1B in cells treated with
epidermal growth factor may be critical for sustaining/enhancing
the receptor tyrosine kinase-mediated signaling pathway [65].
On the other hand, activation of Ras due to S-glutathionylation
in vascular smooth muscle cells in response to angiotensin II
results in stimulation of protein synthesis, potentially leading to
cell hypertrophy [64]. Therefore, S-glutathionylation of proteins
may represent a novel mechanism by which redox modulates
cell signaling and physiology [13]. However, extensive Sglutathionylation of proteins in cells after oxidative stress may
represent the underlying mechanism for oxidant-induced tissue
injury. In this report, we tested whether a deficiency in Grx1, and
therefore a decreased capacity for deglutathionylation, would
sensitize mice to injury in heart and lungs induced by ischemia/
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reperfusion and hyperoxia, respectively, two models in which
the role of ROS in causing tissue damage has been established.
Our results show that mice lacking Grx1 are not more vulnerable
to these two models of oxidant-mediated tissue injury, suggesting that generalized S-glutathionylation of cytosolic proteins,
which is reversible by Grx1, is not a major cause of tissue
damage.
However, these studies do not exclude the physiological role
of Grx1 in other models of oxidant-mediated tissue response and
injury. For example, Cys-179 of the inhibitory κB kinase β
(IKK-β) subunit of inhibitory κB (IκB) kinase is a target of
oxidation, resulting in the formation of IKK-β–SSG mixed
disulfide [66]. This greatly abrogates the kinase activity of
IKK-β, thereby decreasing the phosphorylation of IκB and the
subsequent activation of the transcription factor NF-κB. The
function of Grx1 in preventing oxidation-mediated inactivation
of IKK-β has been demonstrated by experiments using cultured
cells in which expression of Grx1 is either up- or down-regulated
by gene transfection. This conclusion is further supported by the
observations that primary tracheal epithelial cells isolated from
Glrx1−/− mice exhibit attenuated binding activity of NF-κB,
nuclear translocation of the RelA subunit of NF-κB, and
activation of expression of chemokines in response to treatment
with lipopolysaccharide compared to the same cells isolated
from Glrx1+/+ mice [66].
A second example is illustrated by the results that MEFs
deficient in Grx1 are more tolerant to apoptosis induced by
TNFαplus AD (Fig. 7). The molecular mechanism underlying
this observation was suggested by a recent report from Pan and
Beck [67]. In their studies, down-regulation of Grx1 expression
by interference RNA desensitizes human umbilical vein
endothelial cells (HUVECs) to cell death induced by TNFαplus
cycloheximide. This is because treatment of HUVECs with these
agents enhances S-glutathionylation of procaspase-3, which
inhibits its cleavage and activation during the apoptotic
response. In this model of programmed cell death, Grx1 actually
functions in promoting apoptosis by deglutathionylating the
procaspase-3–SSG mixed disulfide, thereby facilitating formation of the active caspase-3. Grx1 can also enhance apoptosis
through a different mechanism. As shown by Nieminen and
colleagues, knock-down of Grx1 attenuates N-acetyl- Lcysteine-induced apoptosis of pancreatic carcinoma cells
exposed to hypoxia [50]. In this case the action of Grx1 is
attributed to its unusual ability to use the glutathionyl radical to
promote S-glutathionylation of the p65 subunit of NF-κB,
thereby inhibiting the antiapoptotic action of NF-κB. These
mechanistic insights indicate that the consequences of protein Sglutathionylation and therefore the role of Grx1 in reversing or
promoting this process may vary in different models of cell
injury and response involving oxidative stress. Thus, this newly
generated line of knockout mice should prove a valuable tool in
addressing the functional role of Grx1 in a variety of disease
models in which cellular redox is perturbed.
The effect of Grx1 deficiency on the response of MEFs to
oxidants was also studied. Lack of Grx1 did not exacerbate the
toxic effects of H2O2 or, surprisingly, diamide, an agent that
more selectively promotes protein–SSG formation, on the
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viability of cells. On the other hand, MEFs deficient in Grx1
were more susceptible to injury induced by diquat or paraquat,
suggesting that different oxidants may damage the cells via
distinct mechanisms, some of which may not be attenuated by
Grx1-dependent deglutathionylation. Furthermore, in the model
of H2O2-induced cell injury, the degree of protein S-glutathionylation seems not to correlate with the extent of cell death, as
more extensive S-glutathionylation of proteins in Grx1-deficient
MEFs is not associated with an increase in cell death (Figs. 5, 6,
and 8). This is also true for MEFs treated with diquat and
paraquat. Both agents cause more cell death in Grx1-deficient
MEFs than in wild-type MEFs, yet no increases in protein Sglutathionylation can be found in either type of MEF at 12 or
24 h posttreatment (data not shown). Although some of these
observations seem to contradict the hypothesis that oxidation of
protein thiols, particularly formation of protein–SSG mixed
disulfides, contributes to oxidant-induced cell damage, there are
several mitigating considerations. First, the time frame of
commitment to cell death is likely much shorter than the time for
progression to cell death. Therefore it is important to examine
early events associated with changes in S-glutathionylation
status and relative rates of deglutathionylation. Second,
examination of gross changes in protein–SSG status may not
be reflective of specific molecular events associated with
commitment to cell death. Because the sensitivity of the
monoclonal antibody against GSH has not yet been characterized and the separation on an SDS gel is relatively limited, Sglutathionylation of certain proteins that play a critical role in the
cellular injury response to oxidants may not be detected due to
the limited sensitivity of the antibody, or they may be masked by
the proteins with a high degree of S-glutathionylation (Fig. 8).
Third, the use of cell death as an end point may not be
appropriate for correlating the extent of cell injury to the level of
protein S-glutathionylation. Nevertheless, overexpression of
Grx1 has been shown to prevent cells from oxidant-mediated
damage in response to dopamine, H2O2, and high concentrations
of glucose [21–26]. These results support the hypothesis that
oxidant-induced cell injury is partly mediated through Sglutathionylation of proteins. However, direct measures of
protein–SSG status of specific proteins in these studies were not
performed, so it remains to be determined whether an increased
expression of Grx1 affects the levels of protein S-glutathionylation in each case.
Finally, MEFs deficient in Grx1 are more vulnerable than
wild-type MEFs to S-glutathionylation of proteins induced by
a high concentration of H2O2 (Fig. 8A), indicating that Grx1 is
an important cellular mechanism of deglutathionylation, as
also shown in several previous studies [16,17,64,66–68]. For
example, overexpression of Grx1 in cells has been shown to
cause deglutathionylation of several targeted proteins such as
Ras, IKK-β, and procaspase-3 [64,66,67], and down-regulation of Grx1 by RNA interference retards deglutathionylation
of S-glutathionylated IKK-β, procaspase-3, and actin [66–68].
The current and other earlier studies suggest that Grx1 may
preferentially deglutathionylate certain cellular proteins.
Further studies to identify the protein targets of Grx1-mediated
deglutathionylation should advance our understanding in

redox regulation of cellular function and oxidant-induced cell
damage.
In summary, a line of knockout mice deficient in Grx1 was
generated in this study for understanding the role of this protein
in oxidant-mediated cell and tissue injury. Our studies showed
that a deficiency in Grx1 does not affect the susceptibility of
mice to acute injury of heart and lungs induced by ischemia/
reperfusion and hyperoxia, respectively. This observation may
preclude a role for Grx1 in protection of the heart and lung cells.
However, at present we cannot exclude the possibility that
alternative or compensatory regulatory mechanisms may have
developed in these mice, which are deprived of Grx1 at the
embryonic stage. On the other hand, we observed that Grx1
deficiency selectively sensitizes MEFs to oxidant-induced cell
death and that Grx1 may exert its function on specific protein
targets. These results indicate the complexity of the mechanisms
by which each oxidant causes cell injury. Identification of the
cellular protein targets of S-glutathionylation that are formed
due to alteration of cellular redox status and after oxidative stress
using this line of knockout mice should provide new insights
into our understanding of cell and tissue physiology in both
health and disease.
Acknowledgments
We thank Dr. Richard Mulligan of Harvard University and
Dr. Andras Nagy of Mount Sinai Hospital in Toronto for the gifts
of plasmid pPNT and R1 embryonic stem cells, respectively;
Syntex, Inc. (Palo Alto, CA, USA) for the gift of ganciclovir; Mr.
Xiufeng Gao and Dr. David Bassett of Wayne State University
for assistance in studies of the bronchoalveolar lavage fluid; and
Ms. Ping T. Ho for sequencing the entire mouse Glrx1 gene. The
work was supported by NIH Grant HL63317 and American
Heart Association Greater Midwest Affiliate Grant 0455876Z to
Y.-S.H.; by NIH Grant HL87271, a grant from the Department of
Veterans Affairs Merit Review, and a grant-in-aid from the
American Heart Association Southeast Affiliate to B.H.L.C.;
and by NIH Grants AG024413 and AG15885 and a Merit
Review grant from the Department of Veterans Affairs to J.J.M.
The use of equipment in the Imaging and Cytometry Facility
Core and Cell Culture Facility Core was supported by Center
Grant P30 ES06639.
References
[1] Cross, C. E.; Halliwell, B.; Borish, E. T.; Pryor, W. A.; Ames, B. N.; Saul,
R. L.; McCord, J. M.; Harman, D. Oxygen radicals and human disease.
Ann. Intern. Med. 107:526–545; 1987.
[2] Stadtman, E. R. Oxidation of free amino acids and amino acid residues in
proteins by radiolysis and by metal-catalyzed reactions. Annu. Rev.
Biochem. 62:797–821; 1993.
[3] Biteau, B.; Labarre, J.; Toledano, M. B. ATP-dependent reduction of
cysteine-sulphinic acid by S. cerevisiae sulphiredoxin. Nature 425:
980–984; 2003.
[4] Budanov, A. V.; Sablina, A. A.; Feinstein, E.; Koonin, E. V.; Chumakov,
P. M. Regeneration of peroxiredoxins by p53-regulated sestrins, homologs
of bacterial AhpD. Science 304:596–600; 2004.
[5] Chang, T. S.; Jeong, W.; Woo, H. A.; Lee, S. M.; Park, S.; Rhee, S. G.
Characterization of mammalian sulfiredoxin and its reactivation of

Y.-S. Ho et al. / Free Radical Biology & Medicine 43 (2007) 1299–1312

[6]

[7]
[8]

[9]
[10]

[11]

[12]
[13]

[14]
[15]

[16]

[17]

[18]
[19]

[20]

[21]
[22]

[23]

[24]

[25]

hyperoxidized peroxiredoxin through reduction of cysteine sulfinic acid in
the active site to cysteine. J. Biol. Chem. 279:50994–51001; 2004.
Woo, H. A.; Jeong, W.; Chang, T. S.; Park, K. J.; Park, S. J.; Yang, J. S.;
Rhee, S. G. Reduction of cysteine sulfinic acid by sulfiredoxin is specific
to 2-cys peroxiredoxins. J. Biol. Chem. 280:3125–3128; 2005.
Holmgren, A. Thioredoxin and glutaredoxin systems. J. Biol. Chem.
264:13963–13966; 1989.
Yoshitake, S.; Nanri, H.; Fernando, M. R.; Minakami, S. Possible
differences in the regenerative roles played by thioltransferase and
thioredoxin for oxidatively damaged proteins. J. Biochem. 116:42–46;
1994.
Gravina, S. A.; Mieyal, J. J. Thioltransferase is a specific glutathionyl
mixed disulfide oxidoreductase. Biochemistry 32:3368–3376; 1993.
Wollman, E. E.; d'Auriol, L.; Rimsky, L.; Shaw, A.; Jacquot, J.-P.;
Wingfield, P.; Graber, P.; Dessarps, F.; Robin, P.; Galibert, F.; Bertoglio, J.;
Fradelizi, D. Cloning and expression of a cDNA for human thioredoxin.
J. Biol. Chem. 263:15506–15512; 1998.
Spyrou, G.; Enmark, E.; Miranda-Vizuete, A.; Gustafsson, J. Cloning and
expression of a novel mammalian thioredoxin. J. Biol. Chem. 272:
2936–2941; 1997.
Lillig, C. H.; Holmgren, A. Thioredoxin and related molecules—from
biology to health and disease. Antioxid. Redox Signaling 9:25–57; 2007.
Shelton, M. D.; Chock, P. B.; Mieyal, J. J. Glutaredoxin: role in reversible
protein S-glutathionylation and regulation of redox signal transduction and
protein translocation. Antioxid. Redox Signaling 7:348–366; 2005.
Meister, A.; Anderson, M. E. Glutathione. Annu. Rev. Biochem. 52:
711–760; 1983.
Yang, Y.; Jao, S.; Nanduri, S.; Starke, D. W.; Mieyal, J. J.; Qin, J.
Reactivity of the human thioltransferase (glutaredoxin) C7S, C25S, C78S,
C82S mutant and NMR solution structure of its glutathionyl mixed
disulfide intermediate reflect catalytic specificity. Biochemistry
37:17145–17156; 1998.
Jung, C. H.; Thomas, J. A. S-glutathiolated hepatocyte proteins and insulin
disulfides as substrates for reduction by glutaredoxin, thioredoxin, protein
disulfide isomerase, and glutathione. Arch. Biochem. Biophys. 335:61–72;
1996.
Chrestensen, C. A.; Starke, D. W.; Mieyal, J. J. Acute cadmium exposure
inactivates thioltransferase (glutaredoxin), inhibits intracellular reduction
of protein-glutathionyl-mixed disulfides, and initiates apoptosis. J. Biol.
Chem. 275:26556–26565; 2000.
Wells, W. W.; Yang, Y.; Deits, T. L.; Gan, Z. R. Thioltransferases. Adv.
Enzymol. Relat. Areas Mol. Biol. 66:149–201; 1993.
Lundberg, M.; Johansson, C.; Chandra, J.; Enoksson, M.; Jacobsson, G.;
Ljung, J.; Johansson, M.; Holmgren, A. Cloning and expression of a novel
human glutaredoxin (Grx2) mitochondrial and nuclear isoforms. J. Biol.
Chem. 276:26269–26275; 2001.
Gladyshev, V. N.; Liu, A.; Novoselov, S. V.; Krysan, K.; Sun, Q. A.;
Kryukov, V. M.; Kryukov, G. V.; Lou, M. F. Identification of a new
mammalian glutaredoxin (thiotransferase), grx2. J. Biol. Chem. 276:
30374–30380; 2001.
Meyer, E. B.; Wells, W. W. Thiotransferase increases resistance of MCF-7
cells to adriamycin. Free Radic. Biol. Med. 26:770–776; 1999.
Daily, D.; Vlamis-Gardikas, A.; Offen, D.; Mittelman, L.; Melamed, E.;
Holmgren, A.; Barzilai, A. Glutaredoxin protects cerebellar granule
neurons from dopamine-induced apoptosis by activating NF-κB via Ref-1.
J. Biol. Chem. 276:1335–1344; 2001.
Daily, D.; Vlamis-Gardikas, A.; Offen, D.; Mittelman, L.; Melamed, E.;
Holmgren, A.; Barzilai, A. Glutaredoxin protects cerebellar granule
neurons from dopamine-induced apoptosis by dual activation of the Rasphosphoinositide 3-kinase and Jun N-terminal kinase pathways. J. Biol.
Chem. 276:21618–21626; 2001.
Murata, H.; Ihara, Y.; Nakamura, H.; Yodoi, J.; Sumikawa, K.; Kondo, T.
Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of
Akt. J. Biol. Chem. 278:50226–50233; 2003.
Song, J. J.; Rhee, J. G.; Suntharalingam, M.; Walsh, S. A.; Spitz, D. R.;
Lee, Y. J. Role of glutaredoxin in metabolic oxidative stress: glutaredoxin
as a sensor of oxidative stress mediated by H2O2. J. Biol. Chem. 277:
46566–46577; 2002.

1311

[26] Song, J. J.; Lee, Y. J. Differential role of glutaredoxin and thioredoxin in
metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem. J. 373:845–853; 2003.
[27] Park, J. B.; Levine, M. The human glutaredoxin gene: determination of its
organization, transcription start point, and promoter analysis. Gene
197:189–193; 1997.
[28] Tybulewicz, V. C. J.; Crawford, C. E.; Jackson, P. K.; Bronson, R. T.;
Mulligan, R. C. Neonatal lethality and lymphopenia in mice with a
homozygous disruption of the c-abl proto-oncogene. Cell 65:1153–1163;
1991.
[29] Nagy, A.; Rossant, J.; Nagy, R.; Abramow-Newerly, W.; Roder, J. C.
Derivation of completely cell culture-derived mice from early-passage
embryonic stem cells. Proc. Natl. Acad. Sci. USA 90:8424–8428; 1993.
[30] Bradley, A. Production and analysis of chimaeric mice. In: Roberston,
E.J., ed. Tetratocarcinomas and embryonic stem cells: a practical
approach. Oxford: IRL Press; 1987:113–151.
[31] Chirgwin, J. M.; Przybyla, A. E.; MacDonald, R. J.; Rutter, W. J. Isolation
of biologically active ribonucleic acid from sources enriched in
ribonuclease. Biochemistry 18:5294–5299; 1979.
[32] Thomas, P. S. Hybridization of denatured RNA and small DNA fragments
transferred to nitrocellulose. Proc. Natl. Acad. Sci. USA 77:5201–5205;
1980.
[33] Aebi, H. E. Catalase in vitro. Methods Enzymol. 105:121–126; 1984.
[34] Little, C.; Olinescu, R.; Reid, K. G.; O'Brien, P. J. Properties and
regulation of glutathione peroxidase. J. Biol. Chem. 245:3632–3636;
1970.
[35] Srinivasan, U.; Mieyal, P. A.; Mieyal, J. J. pH profiles indicative of ratelimiting nucleophilic displacement in thioltransferase catalysis. Biochemistry 36:3199–3206; 1997.
[36] Chen, Z.; Siu, B.; Ho, Y.-S.; Vincent, R.; Hamdy, R. C.; Chua, B. H. L.
Overexpression of MnSOD protects against myocardial ischemia/reperfusion injury in transgenic mice. J. Mol. Cell. Cardiol. 30:2281–2289; 1998.
[37] Berridge, M. V.; Tan, A. S. Characterization of the cellular reduction of
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT):
subcellular localization, substrate dependence, and involvement of
mitochondrial electron transport in MTT reduction. Arch. Biochem.
Biophys. 303:474–482; 1993.
[38] Yoshida, T.; Maulik, N.; Engelman, R. M.; Ho, Y.-S.; Das, D. K. Targeted
disruption of the mouse Sod1 gene makes the heart vulnerable to ischemic
reperfusion injury. Circ. Res. 86:264–269; 2000.
[39] Yoshida, T.; Maulik, N.; Engelman, R. M.; Ho, Y.-S.; Magnenat, J.-L.;
Rousou, J. A.; Flack, J. E., 3rd; Deatron, D.; Das, D. K. Glutathione
peroxidase knockout mice are susceptible to myocardial ischemia
reperfusion injury. Circulation 96 (Suppl. II):216–220; 1996.
[40] Wang, P.; Chen, H.; Qin, H.; Sankarapandi, S.; Becher, M. W.; Wong, P. C.;
Zweier, J. L. Overexpression of human copper, zinc-superoxide dismutase
(SOD1) prevents postischemic injury. Proc. Natl. Acad. Sci. USA
95:4556–4560; 1998.
[41] Chen, Z.; Oberley, T. D.; Ho, Y.-S.; Chua, C. C.; Siu, B.; Hamdy, R. C.;
Epstein, C. J.; Chua, B. H. L. Overexpression of CuZnSOD in coronary
vascular cells attenuates myocardial ischemia/reperfusion injury. Free
Radic. Biol. Med. 29:589–596; 2000.
[42] Yoshida, T.; Watanabe, M.; Engleman, D. T.; Engleman, R. M.; Schley, J.;
Maulik, N.; Ho, Y.-S.; Oberley, T. D.; Das, D. K. Transgenic mice
overexpressing glutathione peroxidase are resistant to myocardial ischemia
reperfusion injury. J. Mol. Cell. Cardiol. 28:1759–1767; 1996.
[43] Crapo, J. D.; Barry, B. E.; Foscue, H. A.; Shelburne, J. Structural and
biochemical changes in rat lungs occurring during exposure to lethal and
adaptive doses of oxygen. Am. Rev. Respir. Dis. 122:123–143; 1980.
[44] Wispe, J. R.; Warner, B. B.; Clark, J. C.; Dey, C. R.; Neuman, J.; Glasser,
S. W.; Crapo, J. D.; Chang, L. -Y.; Whitsett, J. A. Human Mn-superoxide
dismutase in pulmonary epithelial cells of transgenic mice confers
protection from oxygen injury. J. Biol. Chem. 267:23937–23941; 1992.
[45] Folz, R. J.; Abushamaa, A. M.; Suliman, H. B. Extracellular superoxide
dismutase in the airways of transgenic mice reduces inflammation and
attenuates lung toxicity following hyperoxia. J. Clin. Invest. 103:
1055–1066; 1999.
[46] Wang, Y.; Phelan, S. A.; Manevich, Y.; Feinstein, S. I.; Fisher, A. B.

1312

[47]

[48]

[49]

[50]

[51]
[52]

[53]

[54]

[55]

[56]

[57]

[58]

Y.-S. Ho et al. / Free Radical Biology & Medicine 43 (2007) 1299–1312
Transgenic mice overexpressing peroxiredoxin 6 show increased resistance to lung injury in hyperoxia. Am. J. Respir. Cell Mol. Biol. 34:
481–486; 2006.
Carlsson, L. M.; Jonsson, J.; Edlund, T.; Marklund, S. L. Mice lacking
extracellular superoxide dismutase are more sensitive to hyperoxia. Proc.
Natl. Acad. Sci. USA 92:6264–6268; 1995.
Wang, Y.; Feinstein, S. I.; Manevich, Y.; Ho, Y.-S.; Fisher, A. B. Lung
injury and mortality with hyperoxia are increased in peroxiredoxin 6 genetargeted mice. Free Radic. Biol. Med. 37:1736–1743; 2004.
LeBras, M.; Clement, M. V.; Pervaiz, S.; Brenner, C. Reactive oxygen
species and the mitochondrial signaling pathway of cell death. Histol.
Histopathol. 20:205–219; 2005.
Qanungo, S.; Starke, D. W.; Pai, H. V.; Mieyal, J. J.; Nieminen, A. L.
Glutathione supplementation potentiates hypoxic apoptosis by Sglutathionylation of p65-NFκB. J. Biol. Chem. 282:18427–18436;
2007.
Tu, B. P.; Weissman, J. S. Oxidative protein folding in eukaryotes:
mechanisms and consequences. J. Cell Biol. 164:341–346; 2004.
Thorpe, C.; Hoober, K. L.; Raje, S.; Glynn, N. M.; Burnside, J.; Turi,
G. K.; Coppock, D. L. Sulfhydryl oxidases: emerging catalysts of protein
disulfide bond formation in eukaryotes. Arch. Biochem. Biophys. 405:
1–12; 2002.
Lisowsky, T. ERV1 is involved in the cell-division cycle and the maintenance of mitochondrial genomes in Saccharomyces cerevisiae. Curr.
Genet. 26:15–20; 1994.
Lange, H.; Lisowsky, T.; Gerber, J.; Muhlenhoff, U.; Kispal, G.; Lill, R. An
essential function of the mitochondrial sulfhydryl oxidase Erv1p/ALR in
the maturation of cytosolic Fe/S proteins. EMBO Rep. 2:715–720; 2001.
Matsui, M.; Oshima, M.; Oshima, H.; Takaku, K.; Maruyama, T.; Yodoi,
J.; Taketo, M. M. Early embryonic lethality caused by targeted disruption
of the mouse thioredoxin gene. Dev. Biol. 178:179–185; 1996.
Nonn, L.; Williams, R. R.; Erickson, R. P.; Powis, G. The absence of
mitochondrial thioredoxin 2 causes massive apoptosis, exencephaly, and
early embryonic lethality in homozygous mice. Mol. Cell. Biol. 23:
916–922; 2003.
Pineda-Molina, E.; Klatt, P.; Vazquez, J.; Marina, A.; de Lacoba, M. G.;
Perez-Sala, D.; Lamas, S. Glutathionylation of the p50 subunit of NF-κB: a
mechanism for redox-induced inhibition of DNA binding. Biochemistry
40:14134–14142; 2001.
Bandyopadhyay, S.; Starke, D. W.; Mieyal, J. J.; Gronostajski, R. M.

[59]

[60]

[61]

[62]

[63]

[64]

[65]

[66]

[67]

[68]

Thioltransferase (glutaredoxin) reactivates the DNA-binding activity of
oxidation-inactivated nuclear factor I. J. Biol. Chem. 273:392–397; 1998.
Barrett, W. C.; DeGnore, J. P.; Konig, S.; Fales, H. M.; Keng, Y.; ZhongYin, Z.; Yim, M. B.; Chock, P. B. Regulation of PTP1B via glutathionylation of the active site cysteine 215. Biochemistry 38:6699–6705;
1999.
Barrett, W. C.; DeGnore, J. P.; Keng, Y.; Zhang, Z.; Yim, M. B.; Chock,
P. B. Roles of superoxide radical anion in signal transduction mediated by
reversible regulation of protein-tyrosine phosphatase 1B. J. Biol. Chem.
274:34543–34546; 1999.
Ward, N. E.; Stewart, J. R.; Ioannides, C. G.; O'Brian, C. A. Oxidantinduced S-glutathiolation inactivates protein kinase C-α(PKC-α): a
potential mechanism of PKC isozyme regulation. Biochemistry 39:
10319–10329; 2000.
Davis, D. A.; Newcomb, F. M.; Starke, D. W.; Ott, D. E.; Mieyal, J. J.;
Yarchoan, R. Thioltransferase (glutaredoxin) is detected within HIV-1 and
can regulate the activity of glutathionylated HIV-1 protease in vitro.
J. Biol. Chem. 272:25935–25940; 1997.
Dafre, A. L.; Sies, H.; Akerboom, T. Protein S-thiolation and regulation of
microsomal glutathione transferase activity by the glutathione redox
couple. Arch. Biochem. Biophys. 332:288–294; 1996.
Adachi, T.; Pimentel, D. R.; Heibeck, T .; Hou, X.; Lee, Y. L.; Jiang, B.;
Ido, Y.; Cohen, R. A. S-glutathiolation of Ras mediates redox-sensitive
signaling by angiotensin II in vascular smooth muscle cells. J. Biol. Chem.
279: 29857–29862; 2004.
Lee, S. R.; Kwon, K. S.; Kim, S. R.; Rhee, S. G. Reversible inactivation of
protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal
growth factor. J. Biol. Chem. 273:15366–15372; 1998.
Reynaert, N. L.; van der Vliet, A.; Guala, A. S.; McGovern, T.; Hristova,
M.; Pantano, C.; Heintz, N. H.; Heim, J.; Ho, Y.-S.; Matthews, D. E.;
Wouters, E. F. M.; Janseen-Heininger, Y. M. W. Dynamic redox control of
NF-κB through glutaredoxin-regulated S-glutathionylation of inhibitory
κB kinase β. Proc. Natl. Acad. Sci. USA 103:10386–10391; 2006.
Pan, S.; Berk, B. C. Glutathiolation regulates tumor necrosis factor-αinduced caspase-3 cleavage and apoptosis: key role for glutaredoxin in the
death pathway. Circ. Res. 100:213–219; 2007.
Wang, J.; Tekle, E.; Outrahim, H.; Mieyal, J. J.; Stadtman, E. R.; Chock,
P. B. Stable and controllable RNA interference: investigating the
physiological function of glutathionylated actin. Proc. Natl. Acad. Sci.
USA 100:5103–5106; 2003.

